115 related articles for article (PubMed ID: 9286420)
1. Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
Coventry BJ; Austyn JM; Chryssidis S; Hankins D; Harris A
Adv Exp Med Biol; 1997; 417():571-7. PubMed ID: 9286420
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.
Hillenbrand EE; Neville AM; Coventry BJ
Br J Cancer; 1999 Feb; 79(5-6):940-4. PubMed ID: 10070894
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expression.
Coventry BJ; Lee PL; Gibbs D; Hart DN
Br J Cancer; 2002 Feb; 86(4):546-51. PubMed ID: 11870535
[TBL] [Abstract][Full Text] [Related]
4. CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
Coventry BJ
Anticancer Res; 1999; 19(4B):3183-7. PubMed ID: 10652609
[TBL] [Abstract][Full Text] [Related]
5. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
[TBL] [Abstract][Full Text] [Related]
6. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating dendritic/Langerhans cells in primary breast cancer.
Tsuge T; Yamakawa M; Tsukamoto M
Breast Cancer Res Treat; 2000 Jan; 59(2):141-52. PubMed ID: 10817349
[TBL] [Abstract][Full Text] [Related]
8. CD1a in human cancers: a new role for an old molecule.
Coventry B; Heinzel S
Trends Immunol; 2004 May; 25(5):242-8. PubMed ID: 15099564
[No Abstract] [Full Text] [Related]
9. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
10. Assessment of maturation status of tumor-infiltrating dendritic cells in invasive ductal carcinoma of the breast: relation with vascular endothelial growth factor expression.
El Deeb NM; Mehanna RA
Turk Patoloji Derg; 2013; 29(3):193-200. PubMed ID: 24022309
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence.
Kocián P; Šedivcová M; Drgáč J; Cerná K; Hoch J; Kodet R; Bartůňková J; Špíšek R; Fialová A
Hum Immunol; 2011 Nov; 72(11):1022-8. PubMed ID: 21884745
[TBL] [Abstract][Full Text] [Related]
13. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
[TBL] [Abstract][Full Text] [Related]
14. Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy.
Minesaki A; Kai K; Kuratomi Y; Aishima S
BMC Cancer; 2021 Aug; 21(1):973. PubMed ID: 34461859
[TBL] [Abstract][Full Text] [Related]
15. CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients.
Giorello MB; Matas A; Marenco P; Davies KM; Borzone FR; Calcagno ML; García-Rivello H; Wernicke A; Martinez LM; Labovsky V; Chasseing NA
Breast Cancer; 2021 Nov; 28(6):1328-1339. PubMed ID: 34240315
[TBL] [Abstract][Full Text] [Related]
16. Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer.
Zhang Z; Huang J; Zhang C; Yang H; Qiu H; Li J; Liu Y; Qin L; Wang L; Hao S; Zhang F; Wang X; Shan B
Cancer Gene Ther; 2015 Mar; 22(4):198-206. PubMed ID: 25721210
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes.
Thomachot MC; Bendriss-Vermare N; Massacrier C; Biota C; Treilleux I; Goddard S; Caux C; Bachelot T; Blay JY; Menetrier-Caux C
Int J Cancer; 2004 Jul; 110(5):710-20. PubMed ID: 15146561
[TBL] [Abstract][Full Text] [Related]
18. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules.
McMullen TP; Lai R; Dabbagh L; Wallace TM; de Gara CJ
Clin Exp Immunol; 2010 Jul; 161(1):81-8. PubMed ID: 20408858
[TBL] [Abstract][Full Text] [Related]
19. Antigen presenting and primary in vitro sensitizing capacity of CD1a+ dendritic cells generated from human blood.
Degwert J; Steckel F; Hoppe U
Adv Exp Med Biol; 1995; 378():187-9. PubMed ID: 8526051
[No Abstract] [Full Text] [Related]
20. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
